Home ยป Novembre 2022 Dapagliflozin Increases pAMPK, Reduces Fibrosis/Hypertrophy and NLRP-3, IL-6 and Galectin-3 Levels in Short-Term Doxorubicin-Treated Mice Improving Cardiac Function
2022Eventi

Novembre 2022
Dapagliflozin Increases pAMPK, Reduces Fibrosis/Hypertrophy and NLRP-3, IL-6 and Galectin-3 Levels in Short-Term Doxorubicin-Treated Mice Improving Cardiac Function

di adminweb